PLSM Stock News & Catalysts

FEATURED

Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer

Expanded commercial team to accelerate U.S. growth as demand for accessible prenatal care and federal rural health investments create new opportunitiesRAMAT GAN, Israel, Oct. 13, 2026 /PRNewswire/ -- Pulsenmore Ltd.

Summary

Oct 13, 2026, 7:00 AM ·PRNewswire

RECENT

Pulsenmore Expands Its Fertility Platform into the UK

MHRA registration allows Pulsenmore FC to be marketed across the United Kingdom and Northern Ireland, extending the Company's home ultrasound platform into the UK fertility market where more than 100,000 IVF and

Sep 17, 2026, 7:00 AM ·PRNewswire

Pulsenmore Expands into Fertility Care: Completes CE European Registration of Home Ultrasound System for Follicular Monitoring

The Pulsenmore FC system is designed to enable women undergoing IVF and fertility preservation treatments to self-perform ultrasound scans from home This registration marks the Company's second product authorized in

Sep 8, 2026, 7:00 AM ·PRNewswire

Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026

Management to Host Webcast today at 8:30 am ET to discuss Results and Provide Business UpdateOMER, Israel, Aug. 31, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a leading innovator in remote

Aug 31, 2026, 7:00 AM ·PRNewswire

Pulsenmore Ltd. To Announce Financial Results and Business Highlights and Hold Conference Call for the First Half of 2026

OMER, Israel, Aug. 24, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a leading innovator in remote maternal-fetal healthcare and home ultrasound solutions, today announces that it will release its

Aug 24, 2026, 7:00 AM ·PRNewswire

Pulsenmore Expands Its Home Ultrasound Activity in Israel: Ichilov Adopts the Technology, Expanding Access to At-Home Pregnancy Monitoring

The Company's home ultrasound technology will be integrated at Lis Maternity and Women's Hospital at Ichilov, expanding the ability to incorporate at-home ultrasound scans as part of pregnancy monitoringRAMAT

Aug 19, 2026, 7:00 AM ·PRNewswire

Pulsenmore Receives Second AI Grant Within One Month: Israel Innovation Authority Approves $1.27 Million for SmartScan AI Program

The new grant brings the total AI grants approved for Pulsenmore over the past month to approximately $1.6 million, supporting two programs with a combined scope of approximately $3.12 million.The program is designed to

Aug 17, 2026, 7:00 AM ·PRNewswire

These Small Caps are Turning Up the Heat

DENVER, July 13, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- From a transformational merger and corporate restructuring at Twin Vee PowerCats, to encouraging Phase 2 clinical data from Q32 Bio, major oncology

Jul 13, 2026, 10:48 AM ·Globe Newswire

Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead an $1 Million AI Development Project

The program is designed to enable Pulsenmore to develop and clinically validate AI applications that improve clinical workflow efficiency and enhance the scalability of the company's home ultrasound platform. RAMAT

Jul 13, 2026, 7:00 AM ·PRNewswire

Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor

RAMAT GAN, Israel, June 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it has entered into a securities purchase agreement with a

Jun 25, 2026, 8:00 AM ·PRNewswire

Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States

FDA-authorized home ultrasound technology to be integrated into Ouma Health's virtual maternity care model, creating a scalable pathway to expand the adoption of home ultrasound in prenatal care across the United

Jun 24, 2026, 7:00 AM ·PRNewswire

Pulsenmore Announces Full Year 2025 Financial Results and Webcast

Management to Host Conference Call and Webcast today at 8:30am ET to Discuss Results and Provide Business Update OMER, Israel, March 30, 2026 /PRNewswire/ – Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home

Mar 30, 2026, 8:29 AM ·PRNewswire

Pulsenmore Announces Full Year 2025 Earnings Conference Call

OMER, Israel, March 25, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it will release its financial results for full year 2025 on March 30,

Mar 25, 2026, 8:00 AM ·PRNewswire

Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance

OMER, Israel, Feb. 9, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a new commercial engagement with TLC Perinatal PA, a maternal-fetal medicine

Feb 9, 2026, 7:00 AM ·PRNewswire

Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center

OMER, Israel, Feb. 2, 2026 /PRNewswire/ -- Pulsenmore Ltd. (NASDAQ:PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the United States,

Feb 2, 2026, 7:13 AM ·PRNewswire

Pulsenmore Ltd. Ordinary Shares PLSM · News